Ziopharm Oncology

Ziopharm Oncology

Biotechnology, 8030 El Rio St, Houston, Texas, 77054, United States, 51-200 Employees

alaunos.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is ZIOPHARM ONCOLOGY

Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty g...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ZIOPHARM ONCOLOGY

Ziopharm Oncology Org Chart and Mapping

Kevin Boyle

Chief Executive Officer

VP-Level
Employees

Amanda Montoya

Sr. Manufacturing Associate

Mariam Khalil

Biomarker Discovery Scientist II

Brittany Hines

Customer Service Representative

Jan Stevens

Senior Director, Clinical Operations

Erin Cox

Senior Director, Investor Relations & Corporate Communications

Victor Carpio

Associate Director of Analytical Development and Quality Control

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Ziopharm Oncology

Answer: Ziopharm Oncology's headquarters are located at 8030 El Rio St, Houston, Texas, 77054, United States

Answer: Ziopharm Oncology's phone number is 61********

Answer: Ziopharm Oncology's official website is https://alaunos.com

Answer: Ziopharm Oncology's revenue is $50 Million to $100 Million

Answer: Ziopharm Oncology's SIC: 2836

Answer: Ziopharm Oncology's NAICS: 325414

Answer: Ziopharm Oncology has 51-200 employees

Answer: Ziopharm Oncology is in Biotechnology

Answer: Ziopharm Oncology contact info: Phone number: 61******** Website: https://alaunos.com

Answer: Alaunos Therapeutics is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenic genes including KRAS, TP53 and EGFR.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access